Listen to audio brief:

President Trump is focused on revitalizing the American pharmaceutical and biotechnology sectors.

Recently, Gilead Sciences announced an $11 billion investment to expand its operations in the U.S. This investment is part of a broader initiative by various companies to enhance domestic manufacturing and support American workers, aligning with the President’s goals for national security and economic prosperity.

Original: article